Casodex/Zoladex Hormonal therApy study for assessMent of correlation between PSA & BAI in prOstate cancer patieNts - CHAMPION
Study identifier:NIS-OKR-CAS-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An observational study to assess correlation between Prostate Specific Antigen & Beck Anxiety Index in prostate cancer patients under hormonal therapy
Medical condition
prostate cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Male
Actual Enrollment
1200
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 May 2007
Primary Completion Date: 01 Nov 2008
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2010 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Miyoung Kim
AstraZeneca Korea
